Skip to main content

Editorial team

Chief Editor: Rabia Begum

Rabia studied Biochemistry at Kings College London and received a PhD in neurogenetics from the MRC Prion Unit, UCL Institute of Neurology. Her doctoral research was focused on genetic modifiers of prion disease and mechanisms of disease susceptibility. Her research interests include neurogenomics, clinical genomics and precision medicine. She is based in the London office.

Senior Editor: Roshan Ahmed

Roshan earned her Bachelor’s degree from the University of Chicago where she studied Biology and the History, Philosophy and Social Studies of Science and Medicine. She completed her doctoral research on pancreatic cancer metabolism and preclinical therapeutics at Columbia University and received her PhD in pharmacology and molecular signaling. Her research interests include cancer biology and the microbiome. She is based in the New York office.

Senior Editor: Gerrit John-Schuster

Gerrit holds a Master’s degree in Environmental Science, and completed his PhD in cell and molecular biology at the Philipps-University Marburg, Germany, with a focus on lung inflammation in cystic fibrosis. His postdoctoral work across research centers in Germany, the Netherlands and the US focused on a spectrum of inflammatory diseases including asthma, COPD, pulmonary fibrosis and IBD. His research interests include immunology and infectious diseases. He is based in the New York office.

Associate Editor: Patrik Flammer

Patrik holds an MSc in Molecular and Cell Biology, and completed his DPhil at the University of Oxford working on genetics and epidemiology of human intestinal parasites. His postdoctoral research extended this to include aspects of ancient DNA and epidemiology of infections in past populations. He is based in the London office.

  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Annual Journal Metrics